JFG Life Sciences Foundation of the University of Basel
Overview
JFG Life Sciences Foundation of the University of Basel is a Swiss foundation that supports the transfer of innovation from medical research to industry by investing in early-stage life sciences companies in Switzerland and abroad.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| TECregen | Jan 2026 | Seed | Co-investor |
| NXI Therapeutics | Jun 2024 | Pre Seed | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is JFG Life Sciences Foundation of the University of Basel based?
JFG Life Sciences Foundation of the University of Basel is headquartered in Basel, Switzerland.
When was JFG Life Sciences Foundation of the University of Basel founded?
JFG Life Sciences Foundation of the University of Basel was founded in 2018.
How many portfolio companies does JFG Life Sciences Foundation of the University of Basel have?
JFG Life Sciences Foundation of the University of Basel has 2 portfolio companies in Caplight's dataset.
What are some companies in JFG Life Sciences Foundation of the University of Basel's portfolio?
Portfolio companies visible on Caplight include TECregen, NXI Therapeutics.
What was JFG Life Sciences Foundation of the University of Basel's most recent investment shown here?
JFG Life Sciences Foundation of the University of Basel's most recent investment in this portfolio sample was in TECregen in 2026.
What sectors does JFG Life Sciences Foundation of the University of Basel focus on?
JFG Life Sciences Foundation of the University of Basel focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does JFG Life Sciences Foundation of the University of Basel focus on?
JFG Life Sciences Foundation of the University of Basel typically invests at the Early stage.